Microbot Medical Analyst Ratings
Microbot Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | $20 → $8 | Maintains | Buy |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 01/13/2020 | 1621.85% | HC Wainwright & Co. | $12 → $26 | Reiterates | → Buy |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | $10 → $12 | Reiterates | → Buy |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 11/19/2018 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
| 日期 | 上行/下行空間 | 分析師公司 | 價格目標變化 | 評級變化 | 之前/現今評級 |
|---|---|---|---|---|---|
| 10/18/2023 | 429.8% | HC Wainwright & Co. | → $8 | 重申 | 買入 → 買入 |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → $8 | 重申 | 買入 → 買入 |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → $8 | 重申 | → 買入 |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | 目標價$8→$20 | 維持 | 買入 |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | $19 → $20 | 維持 | 買入 |
| 01/13/2020 | 1621.85% | HC Wainwright & Co. | 目標價$26→$12 | 重申 | → 買入 |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | 10美元 → 12美元 | 重申 | → 買入 |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → $10 | 開始覆蓋 | → 買入 |
| 11/19/2018 | — | Ladenburg Thalmann | 降級 | 買入→中立 |
What is the target price for Microbot Medical (MBOT)?
Microbot Medical (MBOT)的目標價是多少？
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on October 18, 2023. The analyst firm set a price target for $8.00 expecting MBOT to rise to within 12 months (a possible 429.80% upside). 4 analyst firms have reported ratings in the last year.
最新的Microbot Medical (NASDAQ:MBOT) 目標價報告是由分析師公司HC Wainwright & Co.於2023年10月18日報道的。該公司預設$8.00的目標價，預計MBOT將在12個月內上漲（可能會上漲429.80%）。在過去一年中，有4個分析師公司報告評級。
What is the most recent analyst rating for Microbot Medical (MBOT)?
Microbot Medical (MBOT)最近的分析師評級是什麼?
The latest analyst rating for Microbot Medical (NASDAQ: MBOT) was provided by HC Wainwright & Co., and Microbot Medical reiterated their buy rating.
Microbot Medical (NASDAQ: MBOT)最新的分析師評級是由HC Wainwright & Co.提供的，並且Microbot Medical重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Microbot Medical (MBOT)的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
分析師在進行廣泛的研究後才會到達股票評級，其中包括查閱公共財務報表，與Microbot Medical的高管和客戶交談，並聽取盈利電話會議的講話。大多數分析師每三個月會這樣做一次，因此您每年應該能夠獲得公司每個企業每年4次評級。Microbot Medical的最後一個評級是在2023年10月18日提交的，因此您應該期望下一個評級在2024年10月18日左右提供。
Is the Analyst Rating Microbot Medical (MBOT) correct?
分析師評級Microbot Medical (MBOT)是否正確？
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a reiterated with a price target of $0.00 to $8.00. The current price Microbot Medical (MBOT) is trading at is $1.51, which is within the analyst's predicted range.
雖然評級是主觀的並且會改變，但最新的Microbot Medical (MBOT)評級是在介於$0.00到$8.00的目標價中重申。Microbot Medical (MBOT)的當前價格爲$1.51，這在分析師的預測範圍內。